1) Eight million new TB cases and two million deaths by TB are estimated each year.
Tuberculosis (TB) is one of the most common causes of morbidity and mortality in human immunodeficiency virus (HIV)-positive adults living in poverty. 1) Eight million new TB cases and two million deaths by TB are estimated each year.
2) It is now generally accepted that the requirement for minimum 6 months treatment for TB is due to the difficulty in eradicating non-replicating persistent Mycobacterium (M.) tuberculosis. Therefore, new lead compounds, which are effective against M. tuberculosis in both active and dormant states, are urgently needed. Although physiology of latent M. tuberculosis infection is still unclear, hypoxic condition was found to induce dormant state of Mycobacterium sp., which has a drug susceptibility profile resembling that of the latent M. tuberculosis infection. [3] [4] [5] Recently, we have established a screening system for anti-dormant mycobacterial substances. 6, 7) In this assay system, M. tuberculosis H37Rv under hypoxic condition became highly resistant against isoniazid, which is one of the first-line drugs for TB. Thus, the minimum inhibitory concentration (MIC) value of isoniazid against M. tuberculosis H37Rv was 0.05 mg/ml under aerobic condition. While, the MIC value of isoniazid was more than 100 mg/ml under nitrogen atmosphere containing 0.2% oxygen. In the course of our search for anti-dormant mycobacterial substances from marine organisms by using this assay system, we isolated three new aminolipopeptides, named trichoderins A, A1 and B, from the culture of the marine sponge-derived fungus of Trichoderma sp. and determined their chemical structures. 8) Among them, trichoderin A showed most potent anti-microbial activity against the non-pathogenic strain of M. smegmatis (MICϭ0.1 mg/ml), the vaccine strain of M. bovis BCG (MICϭ0.02 mg/ml), and the drug susceptible laboratory strain of M. tuberculosis H37Rv (MICϭ0.12 mg/ml) under the both aerobic condition and hypoxic condition inducing dormant state, while its action-mechanism was not investigated. 8) In this paper, the mechanistic-analysis of trichoderin A is presented. Bacterial Culture Mycobacterium strains were grown in Middlebrook 7H9 broth containing 10% Middlebrook OADC enrichment, 0.2% glycerol, and 0.05% Tween 80, or on Middlebrook 7H10 agar containing 10% Middlebrook OADC enrichment and 0.5% glycerol. Escherichia (E.) coli DH5a was used for cloning and maintaining plasmid and grown in Luria-Bertani (LB) liquid medium. E. coli HB101 was used for construction of the genomic DNA library of M. bovis BCG and grown in LB liquid medium containing 0.3% maltose and 10 mM MgSO 4 . The following concentrations of antibiotics were used 100 mg/ml (carbenicillin), 150 mg/ml (hygromycin B), and 40 mg/ml (kanamycin) for E. coli strains and 50 mg/ml (hygromycin B) and 20 mg/ml (kanamycin) for Mycobacterium strains, respectively.
MATERIALS AND METHODS

Materials
Construction of Genomic DNA Library and Transformation of M. smegmatis mc 2 155 The chromosomal DNA of M. bovis BCG Pasteur was prepared by hexadecyltrimethylammonium bromide (CTAB) method.
9) The chromosomal DNA was then digested with restriction endonuclase Sau3AI to produce approximately 30 kb DNA fragments. Genomic DNA library was constructed in the E. coli-Mycobacterium shuttle cosmid, pYUB145, by using the double cos vector strategy as previously described. 10) Briefly, the left and right arms of pYUB145 were generated by diges- tion with restriction endonuclases of XbaI and BamHI. The fragments of genome were ligated to the both arms of pYUB145. The mixture of ligations were in vitro packaged with packaging mix of MaxPlax Lambda Packaging (Epicentre), and the resulting recombinant cosmids were transduced to E. coli HB101. The transformants of E. coli HB101 were selected on the LB agar plates containing carbenicillin. Over 3ϫ10 5 independent clones were pooled, and cosmids for transformation of M. smegmatis was obtained by large scale DNA preparation using a standard alkaline lysis method.
Action-Mechanism of Trichoderin
In order to prepare transformants of M. smegmatis with genomic DNA library, M. smegmatis mc 2 155 were grown at 37°C as described above until the optical density reached 0.8-1.0 at 600 nm. The cultures were centrifuged, and the resulting pellets were washed with 10% glycerol twice and re-suspended in the same solution (1/10th of the initial culture volume). The cell suspensions were mixed with genomic DNA library, and electroporated (2500 V, 25 mFd, 1000 W). The resulting suspensions were incubated at 37°C for 4 h and then plated on Middlebrook 7H10 agar containing 50 mg/ml of hygromycin B.
Isolation of Trichoderin A-Resistant Clones from the Transformants of M. smegmatis with Genomic DNA Library and End Sequencing of Cosmids Trichoderin A-resistant clones were screened from over the 4ϫ10 3 transformants of M. smegmatis with the genomic DNA library by cultivating on the 7H10 agar containing 0.4 mg/ml of trichoderin A. Then, the resistant clones against trichoderin A were grown in the 7H9 broth containing hygromycin B, and cosmids for end sequencing were isolated by using standard alkaline lysis method. The cosmids extracted from the trichoderin A-resistant transformants were subjected to end sequencing (MACROGEN, South Korea). The primers P1 (5Ј-GTACGCCACCGCCTGGTTC-3Ј) and P2 (5Ј-GTGCCAC-CTGACGTCTAAG-3Ј), designed based on the sequence of cosmid vector pYUB415, were used to amplify the integrated end sequences of the cosmids. The obtained sequences were analyzed by BLAST search using the database of BCGList (http://genolist.pasteur.fr/BCGList/) and Comprehensive Microbial Resource in J. Craig Venter Institute (http://cmr.tigr. org/cgi-bin/CMR/CmrHomePage.cgi).
Preparation of the Transformant of M. smegmatis Over-Expressing the Region from atpB Gene to atpH Gene The region from atpB gene to atpH gene was PCR amplified from the cosmid pYUB415_2001 by using the primer pairs T_AtpBH_F (5Ј-AAGCTTGCGCCAGCGAT-GACTGAG-3Ј) and T_AtpBH_R (5Ј-GTTAACTTCAGTCG-GGCAGTCGTG-3Ј). PCR was performed using a program of 30 cycles of 94°C for 15 s, 55°C for 30 s and 68°C for 3 min. Following cloning into pCR2.1-TOPO (Invitrogen) and sequencing, the cloned PCR fragment was excised using the primer-introduced restriction sites (HindIII and HpaI) and cloned into the mycobacterial shuttle plasmid vector pMV261. The transformation of M. smegmatis was performed by the above mentioned method.
Quantification of ATP in the M. bovis BCG M. bovis BCG (3ϫ10 8 colony forming unit (CFU)) in the log phase culture was incubated for 24 h with various concentrations of trichoderin A (MIC 0.02 mg/ml; 5ϫMIC 0.1 mg/ml; 10ϫMIC 0.2 mg/ml), isoinazid (MIC 0.03 mg/ml) or the known inhibitor of ATP synthase, dicyclohexylcarbodiimide (DCCD, 4ϫMIC 100 mg/ml). After incubation, the bacilli were disrupted in the buffer of 100 mM Tris-HCl (pH 7.5) containing 4 mM ethylenediaminetetraacetic acid (EDTA) by 5 cycles of freeze (in methanol and dry ice)-thaw (on ice) with sonication. After centrifugation at 12000 g for 15 min, the supernatant was used for determination of ATP contents using ATP assay system bioluminescence detection kit (Promega). The relative light intensity was measured by using Mithras LB940 (BERTHOLD TECHNOLOGIES), and compared with control. Results are expressed as percentage of inhibition.
Statistical Analysis Data are shown as meanϮS.E. Differences between the data sets were determined by the Dunnett's test. A difference of pϽ0.05 was regarded as significant.
RESULTS AND DISCUSSION
Isolation of Trichoderin A-Resistant Clones from the Transformants of M. smegmatis with Genomic DNA Library
In order to clarify action-mechanism of trichoderin A (Fig. 1) , we first searched the gene, which gives a resistance to trichoderin A, using the genomic DNA library of Mycobacterium bovis BCG, since the transformants over-expressing target proteins often confer drug-resistance. 11, 12) To identify the gene that could confer a resistance to trichoderin A, we prepared transformants of M. smegmatis, which were transformed with the genomic DNA library of M. bovis BCG constructed in the multi-copy shuttle cosmid pYUB145. Then, trichoderin A-resistant clones were screened from over 4000 transformants by the dish culture containing 0.4 mg/ml (4ϫMIC value for M. smegmatis) of trichoderin A. We isolated three transformants, designated ICHO2001, ICHO2002 and ICHO2003, as the resistant strains against trichoderin A (Fig. 2) . Then, each resistant strain was cultured in the Middlebrook 7H9 broth containing hygromycin B, and cosmid were extracted. From the end sequencing of each cosmid, the pYUB145_2001 extracted from ICHO2001 strain and the pYUB145_2002 extracted from ICHO2002 strain were found to contain 31.4 kb (coordinates from 1459821 bp to 1491211 bp) and 29.5 kb (coordinates from 1461913 to 1491443 bp) genome fragments, respectively. While, the cosmid isolated from ICHO2003 strain, named pYUB145_2003, contained the same region of genome as the cosmid pYUB145_2001. These data indicated that the target gene of (Fig. 3) .
Identification of the Gene Causing Resistance to Trichoderin A On the other hand, leucinostatin B, which is a structurally related compound with trichoderin A, has been reported to inhibit the mitochondrial ATP synthase isolated from rat liver. [13] [14] [15] The target region of trichoderin A contained atpB, atpE, atpF, atpH and parts of atpA genes, which coded mycobacterial ATP synthase (Fig. 3) . Therefore, the anti-mycobacterial activity of trichoderin A was presumed to result from the inhibition of mycobacterial ATP synthesis. To confirm this hypothesis, we cloned the region from atpB gene to atpH gene into multi-copy vector pMV261 and then established a transformant of M. smegmatis, which over-expressed the region from atpB gene to atpH gene. As shown in Fig. 4 , the independent transformants, ICHO1005 and ICHO1006, exhibited resistance to 0.4 mg/ml of trichoderin A, whereas no resistance to trichoderin A was observed in the both wildtype strain and transformant of M. smegmatis with empty vector of pMV261 (ICHO1001 stain). This result suggested that the action-mechanism of trichoderin A relates to the gene products of the region from atpB gene to atpH gene.
Effect of Trichoderin A on the ATP Contents of M.
bovis BCG In addition, effect of trichoderin A on the ATP contents was investigated by using M. bovis BCG. As shown in Fig. 5 , the 0.1 mg/ml concentration of trichoderin A reduced the amount of intracellular ATP in the M. bovis BCG as well as dicyclohexylcarbodiimide (DCCD), a known inhibitor of ATP synthase, whereas the ATP contents was not decreased by the treatment of isoniazid, which inhibits inhA of type II fatty acid biosynthetic enzyme. 16) These findings suggested that the anti-mycobacterial activity of trichoderin A comes from the inhibition of ATP synthesis. To date, several anti-mycobacterial agents are undergoing clinical trial. Among them, diarylquinoline, TMC207, was known to inhibit ATP synthesis by binding to the atpE protein. 17) TMC207 is also effective to dormant state of M. tuberculosis. 18) These evidences indicate that trichoderin A might be a possible lead of anti-dormant mycobacterial drugs. The binding protein of trichoderin A and anti-microbial activity of trichoderin A against clinically isolated M. tuberculosis including multi drug resistant (MDR), extensively drug resistant (XDR) and totally drug resistant (TDR) strains are currently under study.
